Motion of material being imaged, particularly flowing blood, can result in many possible effects in the images.
Fast moving blood produces flow voids, blood flowing in to the outer slices of an imaging volume produces high signals (flow related enhancement, entry slice phenomenon), pulsatile flow creates ghost images of the vessel extending across the image in the phase encoding direction (image misregistration).
Flow-related dephasing occurring when spin isochromats are moving with different velocities in an external gradient field G so that they acquire different phases. When these phases vary by more then 180° within a voxel, substantial spin dephasing results leading to considerable intravascular signal loss.
These effects can be understood as caused by time of flight effects (washout or washin due to motion of nuclei between two consecutive spatially selective RF excitations, repeated in times on the order of, or shorter than the relaxation times of blood) or phase shifts (delay between phase encoding and frequency encoding) that can be acquired by excited spins moving along magnetic field gradients.
The inconsistency of the signal resulting from pulsatile flow can lead to artifacts in the image. The flow effects can also be exploited for MR angiography or flow measurements.

See also Flow Artifact.

(FLAIR) Fluid attenuation inversion recovery is a special inversion recovery sequence with long TI to remove the effects of fluid from the resulting images. The TI time of the FLAIR pulse sequence is adjusted to the relaxation time of the component that should be suppressed. For fluid suppression the inversion time (long TI) is set to the zero crossing point of fluid, resulting in the signal being 'erased'.
Lesions that are normally covered by bright fluid signals using conventional T2 contrast are made visible by the dark fluid technique FLAIR is an important technique for the differentiation of brain and spine lesions.

See also Inversion Recovery.

(FID) A free induction decay curve is generated as excited nuclei relax. The amplitude of the FID signal becomes smaller over time as net magnetization returns to equilibrium. If transverse magnetization of the spins is produced, e.g. by a 90° pulse, a transient MR signal will result that will decay toward zero with a characteristic time constant T2 (or T2*); this decaying signal is the free induction decay.
The signal peaks of the echoes fall onto this T2 decay curve, while at each echo the signals arise and decay with T2*. The typical T2 relaxation times being of the order of 5-200 ms in the human body. The first part of the FID is not observable (named the 'receiver dead time') caused by residual effects of the powerful exciting radio frequency pulse on the electronics of the receiver.

Gadolinium oxide (Gd2O3) is a prototype paramagnetic agent for contrast enhanced MRI. Gd2O3 particles have very high relaxivity. With its high magnetic moment, gadolinium reduces the relaxation time and enhance MR signal intensity. All gadolinium compounds are highly toxic. Very stable complexes are developed to eliminate the toxicity. See also Paramagnetic Substance, Paramagnetism, Paramagnetic Contrast Agents and Contrast Agents, the info sheet gives an overview and more in-dept information about different types of MRI Contrast media.

Paramagnetic substances, for example Gd-DTPA solutions, are used as MRI oral contrast agents in gastrointestinal imaging to depict the lumen of the digestive organs. Different Gd-DTPA solutions or zeolites containing gadolinium can be used e.g., for diagnosis of delayed gastric emptying, diagnosis of Crohn's disease etc.
Low concentrations of gastrointestinal paramagnetic contrast agents cause a reduction in T1 relaxation time; consequently, these agents act on T1 weighted images by increasing the signal intensity of the bowel lumen. High concentrations cause T2 shortening by decreasing the signal, similar to superparamagnetic iron oxide. Gd-DTPA chelates are unstable at the low pH in the stomach, therefore buffering is necessary for oral use.

See also Gadopentetate Gastrointestinal, Gadolinium Zeolite, Negative Oral Contrast Agents, Gastrointestinal Superparamagnetic Contrast Agents, and Ferric ammonium citrate.